The New MedTech Imperative: from Insights to Autonomy

The MedTech industry is entering a pivotal stage, moving beyond traditional data-driven insights toward autonomous, intelligent action. While generative AI has gained significant momentum across healthcare, its limitations around safety, explainability, and regulatory compliance make it unsuitable for mission-critical clinical environments. To derive meaningful value, MedTech enterprises must move beyond general-purpose models and adopt purpose-built agentic AI systems that can operate reliably within stringent clinical and regulatory frameworks.

Agentic AI represents the next evolution of MedTech innovation. With autonomous, goal-driven capabilities, ranging from contextual perception and reasoning to planning and executing validated actions, agentic systems, when combined with domain-specific training and edge-optimized Small Language Models (SLMs), can deliver real-time, privacy-preserving, and clinically precise outcomes. These capabilities enable MedTech firms to embed intelligence directly into regulated workflows without compromising safety or compliance.

In this Viewpoint, we explore how MedTech enterprises can deploy agentic AI and SLMs to overcome general–purpose AI’s limitations, supported by practical use cases and market observations. The report also provides a structured roadmap for responsible scaling, emphasizing a brownfield-first approach to accelerate RoI by enhancing existing regulated products, alongside an ecosystem-driven approach to mitigate talent, regulatory, and scaling challenges.